Seattle Genetics, Inc., (NASDAQ:SGEN) a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Its lead product, SGN-35 is in pivotal trial stage used for the treatment of patients with relapsed or refractory hodgkin lymphoma.
In the last week, Baker Brothers Life Sciences has bought nearly $18 million worth of shares. Baker Brothers is currently on the Board of Directors. The stock trades at $17.90 which is fairly higher than the price Baker Brothers bought at.
Morgans Hotel Group Co., (NASDAQ:MHGC) a hospitality company, engages in the ownership, operation, acquisition, development, and redevelopment of boutique hotels in gateway cities and select resort markets primarily in the United States and Europe.
In the last week, Billionaire Ronald W. Burkle has bought over $8 million. He is currently on the Board. This is not that large of an investment for him. However, the company is a small cap with a market cap around $250 million. So relative to the company he has a sizeable stake in it. The stock is about 8% higher than Burkle's average price.
Equity One, Inc., (NYSE:EQY) a real estate investment trust (REIT), engages in the ownership, management, acquisition, renovation, and development of neighborhood and community shopping centers in the United States. Its shopping centers are anchored by supermarkets, drug stores, or discount retail store chains.
Chaim Katzman who owns one of the largest commercial real estate companies in the world has been taking a huge stake in the company. Katzman has been buying shares since May. He has been buying in August nearly every other day. He has bought over $60 million worth of shares. Equity One pays nearly a 5% dividend as it is a REIT.
National Penn Bancshares, Inc. (NASDAQ:NPBC) operates as the bank holding company for National Penn Bank that provides commercial banking products and services to residents and businesses primarily in eastern and central Pennsylvania. It offers various deposit products, including demand, NOW, money market, and other checking and savings accounts, as well as certificates of deposit.
Warburg Pincus, a private equity firm has been buying since mid August. It has bought over $5.5 million worth of shares. Other directors have been buying as well. Michael E. Martin, has bought the same amount of shares. Mr. Martin is a managing director at Warburg Pincus.
To many of these investors, these positions may be small. However you must remember one simple saying. Insiders sell for many reasons, but buy for only one.